SCHEMBL6190376

SCHEMBL6190376

CC(C)(C)OC(=O)N=C(NC(=O)OC(C)(C)C)N1CCc2ccc(OCC3CCN(C(=O)OCc4ccccc4)CC3)cc2C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 11/20 0.48
▸ TMEM97 Q5BJF2 6/20 0.44
▸ SIGMAR1 Q99720 6/20 0.44
▸ CHRM4 P08173 1/20 0.42
▸ HTR1A P08908 1/20 0.42
▸ CHRM5 P08912 1/20 0.42
▸ ADRA2A P08913 1/20 0.42
▸ ADRA2B P18089 1/20 0.42
▸ HRH2 P25021 1/20 0.42
▸ ADRA1D P25100 1/20 0.42
▸ HTR2A P28223 1/20 0.42
▸ HTR2C P28335 1/20 0.42
▸ ADRA1A P35348 1/20 0.42
▸ HRH1 P35367 1/20 0.42
▸ ADRA1B P35368 1/20 0.42
▸ DRD3 P35462 1/20 0.42
▸ HTR2B P41595 1/20 0.42
▸ HTR5A P47898 1/20 0.42
▸ HRH3 Q9Y5N1 1/20 0.42
▸ YAP1 P46937 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6190371 1.00 F10 (0.48) F10TMEM97SIGMAR1CHRM4HTR1A
SCHEMBL6191164 0.91 F10 (0.43) F10TMEM97SIGMAR1ADRA2AADRA2B
SCHEMBL6191166 0.91 F10 (0.43) F10TMEM97SIGMAR1ADRA2AADRA2B
SCHEMBL6190428 0.88 F10 (0.50) F10
SCHEMBL6190422 0.88 F10 (0.50) F10
SCHEMBL6187842 0.87 F10 (0.61) F10HRH3
SCHEMBL6187838 0.87 F10 (0.61) F10HRH3
SCHEMBL6188300 0.87 F10 (0.44) F10
SCHEMBL6188296 0.87 F10 (0.44) F10
SCHEMBL6190651 0.87 F10 (0.56) F10TMEM97SIGMAR1CHRM4HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070714-A9 AMIDINE COMPOUNDS JAPAN TOBACCO INC. (JP) 2005-10-19 — — EP disclosed
EP-1070714-B1 AMIDINE COMPOUNDS JAPAN TOBACCO INC (JP) 2004-08-04 — — EP disclosed
US-20040006099-A1 Amidine compounds JAPAN TOBACCO INC. 2004-01-08 — — US disclosed
US-6562828-B1 Novel amidine compound having a blood coagulation factor Xa inhibitory activity JAPAN TOBACCO INC. (JP) 2003-05-13 — — US disclosed
EP-1070714-A1 AMIDINE COMPOUNDS JAPAN TOBACCO INC. (JP) 2001-01-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006099-A1 Amidine compounds F2, SERPINC1, F12 F10 16/4885TMEM97 4208/4885SIGMAR1 1553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback